Medipharm Labs Corp T.LABS

Management gave no follow up details

[piduks]

after they received the second drug approval from Brazil contrary to what senior management indicated publicly they would do once the second approval was received.   Could that indicate a self imposed quiet period and Medipharm Labs is in some sort of merger talks?  

The name of game is making money and capital gains.   That's all that matters, nothing else when you buy a publicly traded company.

[Solid1]

Well, he's not entirely wrong when it comes to public relations. Medipharm Labs has a lot to do in the background and does not disclose any information to its shareholders... while the share price is pushed further and further down. Normal is different 

[mdjbrown]

piduks, is it possible ANVISA is holding up the announcement party? I havent seen any press releases out of Brazil lately from ANVISA regarding CBD approvals for any companies, and yet corporations are making those claims. Something appears a tad out of alignment........

[QContinuum1]

  Saying a government entity is slow is like saying the sun rises in the east.  That said, it's of less importance that whatever LABS is waiting on and much more important that they receive a nice PO.  If we use Stada as an example, one doesn't always lead to the other.  So sure, waiting on this Brazil announcement is fair game to break the boredom, but if the